Clininfo S.A.   Report issue

For profit Phase 2 Phase 3
Founded: Lyon France (2004)

Organization Overview

First Clinical Trial
2011
NCT01337219
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2015

Timeline

NOW
  • Now

Active Ingredients

Drugs in Phase 3 Trials (2)

dopamine (intropin) (1 trial)

glucose monohydrate (1 trial)

Drugs in Phase 2 Trials (1)

tobramycin (nebcin) (2 trials)

Drugs in Other Trials (1)

ceftazidime (fortaz) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Cystic Fibrosis (Phase 2)

Fibrosis (Phase 2)

Hemorrhage (Phase 3)

Hypotension (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 3
  • # of Trial APIs: 4